Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
[During the Covid-19 pandemic, certain drugs were touted as ‘miracle cures’. One was hydroxychloroquine (HCQ), an anti-malarial drug, which was used for the Covid-19 treatment, despite a lack of evidence for its efficacy and side effects. After WHO stopped recommending HCQ for the treatment of Covid-19 in July 2020, Turkey insisted on using the drug. This article investigates to what extent health policies that are imposed in the name of the common good are received as il/legitimate at the grassroots. How is HCQ treatment received at the grassroots? What tensions exist, if any, between the government health policies and the public response regarding this treatment? How do the patients and doctors react to the use of HCQ in the treatment of Covid-19? What does the administration of a non-evidence-based drug disclose about the healthcare system in Turkey? This chapter draws on ethnographic evidence collected among medical doctors and patients and on media research on the Turkish government’s recognition of the Covid-19 cases in March 2020 and its decision to stop the use of HCQ in May 2021.]
Published: May 4, 2023
Keywords: Turkey; Healthcare system; Covid-19 pandemic; Hydroxychloroquine
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.